Stock Fundamentals

ASND.US Logo

ASND.US - Current Price

$210.49

Company Information

▼
Company Name
Ascendis Pharma AS
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US04351P1012
CIK: 0001612042
CUSIP: 04351P101
Currency: USD
Full Time Employees: 1,017
Phone: 45 70 22 22 44
Website: https://ascendispharma.com
Fiscal Year End: December
IPO Date: Jan 28, 2015
Description:

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

Address:

Tuborg Boulevard 12, Hellerup, Denmark, 2900

Directors & Officers

▼
Name Title Year Born
Mr. Jan Moller Mikkelsen President, CEO, Member of Executive Board & Executive Director 1960
Mr. Scott T. Smith CFO, Executive VP & Member of Executive Board 1974
Ms. Pedersen Anni Lotte Kirstine Sonderbjerg Executive VP, Chief Administrative Officer & Member of the Executive Board 1961
Mr. Michael Wolff Jensen L.L.M. Executive VP, Chief Legal Officer & Member of the Executive Board 1971
Mr. Mads Bodenhoff Senior VP, Head of Finance & Principal Accounting Officer 1969

Shares Statistics

▼
Shares Outstanding: 61.10M
Shares Float: 60.63M
% Insiders: 76.10%
% Institutions: 10,595.10%
Short % Float: 7.05%

Valuation Metrics

▼
Enterprise Value: $13.12B
Trailing P/E: 0.00
Forward P/E: 46.30

Financial Highlights

▼
Market Cap: $12.86B
EBITDA: $-133.71M
Book Value: $-2.85
Earnings/Share: $-4.40
Profit Margin: -36.03%
Operating Margin: 5.15%
ROA (TTM): -7.69%
ROE (TTM): -818.43%
Revenue (TTM): $646.55M
Revenue/Share (TTM): $10.73
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 269.40%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 0.12 N/A -10,000.00%
Sep 30, 2025 -1.00 -0.28 N/A -25,714.29%
Jun 30, 2025 -0.64 -1.31 N/A 5,114.50%
Mar 31, 2025 -1.58 -1.51 N/A -463.58%
Dec 31, 2024 -0.64 -0.93 N/A 3,118.28%
Sep 30, 2024 -1.72 -1.49 N/A -1,543.62%
Jun 30, 2024 -2.11 -1.46 N/A -4,452.05%
Mar 31, 2024 -2.30 -1.50 N/A -5,333.33%
Dec 31, 2023 -1.54 -2.03 N/A 2,413.79%
Sep 30, 2023 -2.88 -2.38 N/A -2,100.84%
Jun 30, 2023 -2.16 -2.59 N/A 1,660.23%
Mar 31, 2023 -1.98 -2.66 N/A 2,556.39%
Dec 31, 2022 -3.70 -2.56 N/A -4,453.13%
Sep 30, 2022 -3.03 -2.49 N/A -2,168.67%
Jun 30, 2022 -1.46 -2.13 N/A 3,145.54%
Mar 31, 2022 -2.21 -2.00 N/A -1,050.00%
Dec 31, 2021 -1.87 -2.34 N/A 2,008.55%
Sep 30, 2021 -1.47 -2.29 N/A 3,580.79%
Jun 30, 2021 -2.50 -2.23 N/A -1,210.76%
Mar 31, 2021 -1.17 -1.71 N/A 3,157.89%
Dec 31, 2020 -2.64 -1.55 N/A -7,032.26%
Sep 30, 2020 -2.31 -1.58 N/A -4,620.25%
Jun 30, 2020 -1.97 -1.44 N/A -3,680.56%
Mar 31, 2020 -1.32 -1.35 N/A 222.22%
Dec 31, 2019 -1.89 -1.62 N/A -1,666.67%
Sep 30, 2019 -0.53 -1.19 N/A 5,546.22%
Jun 30, 2019 -1.25 -1.21 N/A -330.58%
Mar 31, 2019 -1.24 -1.00 N/A -2,400.00%
Dec 31, 2018 -0.86 -1.14 N/A 2,456.14%
Sep 30, 2018 -0.81 -1.07 N/A 2,429.91%
Jun 30, 2018 -0.55 -0.90 N/A 3,888.89%
Mar 31, 2018 -1.07 -0.77 N/A -3,896.10%
Dec 31, 2017 -0.92 -0.80 N/A -1,500.00%
Sep 30, 2017 -1.04 -0.74 N/A -4,054.05%
Jun 30, 2017 -0.94 -0.72 N/A -3,055.56%
Mar 31, 2017 -0.83 -0.75 N/A -1,066.67%
Dec 31, 2016 -0.67 -0.62 N/A -806.45%
Sep 30, 2016 -0.80 -0.68 N/A -1,764.71%
Jun 30, 2016 -0.60 -0.69 N/A 1,304.35%
Mar 31, 2016 -0.54 -0.46 N/A -1,739.13%
Sep 30, 2015 -0.33 -0.60 N/A 4,500.00%
Jun 30, 2015 -0.70 -0.49 N/A -4,285.71%
Mar 31, 2015 0.07 -0.39 N/A 11,794.87%
Dec 31, 2014 -0.65 N/A N/A N/A
Sep 30, 1899 -1.07 -0.76 N/A -4,078.95%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $559.54M $N/A $1.18B $1.29B $-105.71M
2023-12-31 $392.16M $N/A $825.59M $971.28M $-145.70M
2022-12-31 $444.77M $N/A $1.09B $826.39M $263.35M
2021-12-31 $446.27M $N/A $1.08B $201.29M $883.64M
2020-12-31 $584.52M $N/A $979.79M $141.08M $838.71M
2019-12-31 $598.11M $N/A $676.73M $79.62M $597.11M
2018-12-31 $277.86M $N/A $318.97M $38.92M $280.05M
2017-12-31 $195.35M $N/A $210.98M $23.77M $187.21M
2016-12-31 $180.33M $N/A $190.07M $13.46M $176.61M
2015-12-31 $119.65M $N/A $131.77M $11.45M $120.33M
2014-12-31 $50.17M $N/A $58.67M $12.86M $45.81M
2013-12-31 $19.43M $N/A $26.70M $20.40M $6.30M
2012-12-31 $14.54M $N/A $25.41M $23.85M $1.56M
2011-12-31 $15.68M $N/A $22.82M $22.59M $233.00K

Watchlist

0

No stocks in watchlist